Antonio De Leo Selected Research

Antonio De Leo Research Topics

Disease

18	Neoplasms (Cancer) 01/2022 - 01/2011
6	Endometrial Neoplasms (Endometrial Cancer) 02/2022 - 01/2018
5	Carcinoma (Carcinomatosis) 11/2021 - 01/2018
3	Disease Progression 04/2021 - 07/2020
3	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2021 - 01/2019
2	Thyroid Neoplasms (Thyroid Cancer) 12/2022 - 01/2022
2	Microsatellite Instability 01/2022 - 04/2021
2	Sarcoma (Soft Tissue Sarcoma) 07/2020 - 02/2020
2	Leiomyosarcoma 07/2020 - 07/2020
1	Follicular Adenocarcinoma 12/2022
1	Papillary Carcinoma 12/2022
1	Colorectal Neoplasms (Colorectal Cancer) 07/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022
1	Hypoxia (Hypoxemia) 11/2021
1	Neoplasm Metastasis (Metastasis) 11/2021
1	Margins of Excision 11/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2021
1	Wounds and Injuries (Trauma) 02/2021
1	Multiple Primary Neoplasms 02/2021
1	Ovarian Neoplasms (Ovarian Cancer) 01/2021
1	Hyperaldosteronism (Conn Syndrome) 12/2020
1	Adenoma (Adenomas) 12/2020
1	Cushing Syndrome 12/2020
1	Adrenocortical Adenoma (Disease, Conn's) 12/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2020
1	Breast Neoplasms (Breast Cancer) 10/2020
1	Autoimmune Diseases (Autoimmune Disease) 10/2020
1	COVID-19 10/2020
1	Cytokine Release Syndrome 10/2020
1	Carcinogenesis 10/2020
1	Turcot syndrome 09/2020
1	Benign Fibrous Histiocytoma (Dermatofibroma) 02/2020
1	Intraductal Papilloma 01/2018
1	Rare Diseases (Rare Disease) 01/2018
1	Adenosarcoma of the uterus 01/2018
1	Adenosarcoma 01/2018

Drug/Important Bio-Agent (IBA)

4	Biological ProductsIBA 01/2022 - 10/2020
3	DNA (Deoxyribonucleic Acid)IBA 02/2022 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 02/2022 - 09/2020
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
3	CateninsIBA 04/2021 - 01/2018
2	pembrolizumabIBA 01/2022 - 11/2021
2	CytokinesIBA 11/2021 - 11/2021
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2021 - 11/2021
2	NF-kappa B (NF-kB)IBA 11/2021 - 11/2021
2	Immune Checkpoint InhibitorsIBA 11/2021 - 01/2019
2	ParaffinIBA 01/2021 - 01/2011
2	Formaldehyde (Formol)FDA Link 01/2021 - 01/2011
1	RacivirIBA 12/2022
1	ErbB Receptors (EGF Receptor)IBA 07/2022
1	Cytotoxins (Cytolysins)IBA 07/2022
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	Complement System Proteins (Complement)IBA 11/2021
1	Interleukin-15 (Interleukin 15)IBA 11/2021
1	AndrogensIBA 11/2021
1	Interleukin-17 (Interleukin 17)IBA 11/2021
1	Interleukin-6 (Interleukin 6)IBA 11/2021
1	Interleukin-27 (Interleukin 27)IBA 11/2021
1	ChemokinesIBA 11/2021
1	nitroxolineIBA 11/2021
1	AntibodiesIBA 11/2021
1	VaccinesIBA 11/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2021
1	RadiumIBA 11/2021
1	mesoglycanIBA 02/2021
1	Mitochondrial DNA (mtDNA)IBA 02/2021
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2021
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	AldosteroneIBA 12/2020
1	EnzymesIBA 12/2020
1	Hydrocortisone (Cortisol)FDA LinkGeneric 12/2020
1	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 12/2020
1	Messenger RNA (mRNA)IBA 10/2020
1	MicronutrientsIBA 10/2020
1	TenascinIBA 10/2020
1	Antiviral Agents (Antivirals)IBA 10/2020
1	Protein Isoforms (Isoforms)IBA 10/2020
1	PeriostinIBA 10/2020
1	OsteopontinIBA 10/2020
1	VitaminsIBA 10/2020
1	MutL Protein Homolog 1IBA 09/2020
1	Cathepsin KIBA 02/2020
1	Capsules (Microcapsules)IBA 01/2020
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2020
1	Chromogranin AIBA 01/2018
1	Epirubicin (Ellence)FDA LinkGeneric 01/2018
1	SynaptophysinIBA 01/2018
1	Ifosfamide FDA LinkGeneric 01/2018
1	Exonucleases (3' 5' Exonuclease)IBA 01/2018

Therapy/Procedure

3	Therapeutics 07/2022 - 10/2020
3	Drug Therapy (Chemotherapy) 04/2021 - 07/2020
2	Castration 01/2022 - 11/2021
2	Radiotherapy 12/2021 - 11/2021
2	Immunotherapy 11/2021 - 11/2021
1	Prostatectomy (Retropubic Prostatectomy) 12/2021
1	Cesarean Section (Caesarean Section) 02/2021
1	Adjuvant Chemotherapy 07/2020